Investments
28Portfolio Exits
8Funds
1About Merieux Developpement
Merieux Developpement is an evergreen fund specialized in the healthcare sector, conducting growth and venture capital investments worldwide. Merieux Developpement works alongside entrepreneurs whose products and services can bring genuine advances to the health of patients and consumers, offering them access to its industry expertise and global network. Merieux Developpement is an affiliate of Institut Merieux, which employs around 13,000 employees worldwide with consolidated revenues exceeding EUR 2.0 billion in 2013. Other companies owned by Institut Merieux include bioMerieux (in vitro diagnostics), Merieux NutriSciences (food safety and nutrition services) and Transgene (immunotherapy).

Want to inform investors similar to Merieux Developpement about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing Merieux Developpement
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Merieux Developpement in 1 Expert Collection, including Synthetic Biology.
Synthetic Biology
382 items
Latest Merieux Developpement News
Jun 1, 2023
Paris-based TISSIUM, a medtech company developing biomorphic programmable polymers for tissue reconstruction, announced that it has closed €50M in a Series D round of funding. The financing comes from new and existing international investors, including Fonds Stratégique des Transitions, managed by ISALT, Merieux Developpement and returning Cathay Health, Credit Mutuel Innovation, and Sofinnova Partners. TISSIUM claims this latest round of funding comes at a time of significant milestones for the company, including its ongoing first-in-human study on its first nerve repair product — COAPTIUM Connect, in Australia and multiple ongoing regulatory activities. This funding will enable the French company to continue executing its development plan, supporting the commercialization of its initial nerve and hernia repair products. Furthermore, the capital will facilitate the expansion of its’s product pipeline and platform. TISSIUM intends to advance the development and commercialization of products derived from its unique biopolymer platform. According to the company, its products will address multiple unmet clinical needs, including atraumatic tissue repair and reconstruction. At the core of TISSIUM’s technology platform lies a proprietary family of fully biosynthetic, biomorphic, and programmable polymers.
Merieux Developpement Investments
28 Investments
Merieux Developpement has made 28 investments. Their latest investment was in Keranova as part of their Series B on September 9, 2019.

Merieux Developpement Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
9/10/2019 | Series B | Keranova | $26.51M | No | Financiere Arbevel, Merieux Developpement, Supernova Invest, Tourrette Investissements, and Undisclosed Investors | 1 |
5/28/2019 | Seed | Waoup | $2.79M | Yes | 1 | |
4/4/2019 | Series C - IV | Inscripta | $20M | No | 5 | |
12/19/2018 | Series C - III | |||||
5/3/2018 | Private Equity |
Date | 9/10/2019 | 5/28/2019 | 4/4/2019 | 12/19/2018 | 5/3/2018 |
---|---|---|---|---|---|
Round | Series B | Seed | Series C - IV | Series C - III | Private Equity |
Company | Keranova | Waoup | Inscripta | ||
Amount | $26.51M | $2.79M | $20M | ||
New? | No | Yes | No | ||
Co-Investors | Financiere Arbevel, Merieux Developpement, Supernova Invest, Tourrette Investissements, and Undisclosed Investors | ||||
Sources | 1 | 1 | 5 |
Merieux Developpement Portfolio Exits
8 Portfolio Exits
Merieux Developpement has 8 portfolio exits. Their latest portfolio exit was Ivantis on November 08, 2021.
Merieux Developpement Acquisitions
2 Acquisitions
Merieux Developpement acquired 2 companies. Their latest acquisition was STIPlastics on January 18, 2018.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
1/18/2018 | Acq - Fin - II | 2 | ||||
3/21/2016 |
Date | 1/18/2018 | 3/21/2016 |
---|---|---|
Investment Stage | ||
Companies | ||
Valuation | ||
Total Funding | ||
Note | Acq - Fin - II | |
Sources | 2 |
Merieux Developpement Fund History
1 Fund History
Merieux Developpement has 1 fund, including Merieux Developpement II.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
Merieux Developpement II | $188.35M | 1 |
Closing Date | |
---|---|
Fund | Merieux Developpement II |
Fund Type | |
Status | |
Amount | $188.35M |
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.